A Transformation in Cancer Drug Discovery

With precision screens of drug-like small molecules, our researchers unearth a new generation of therapies for some of the most aggressive cancers.

Harnessing chemical biology for cancer drug discovery


Wednesday, October 14, 2020 | 1:00 p.m. PT/4:00 p.m. ET

Gene regulation is the study of how cells turn certain genes on or off and plays a central role in the development and treatment of cancer. In this Front Row lecture, Associate Professor Michael Erb will share his research applying chemical tools to study how chromatin, a molecular machine that plays a key role in transcription, becomes disrupted in cancer. He will discuss his research developing small molecule drugs targeting these genetic malfunctions.

Photo of Michael Erb, PhD

Michael Erb, PhD
Associate Professor
Department of Chemistry